# EDGAR Filing Document

**Accession Number:** 0001932231
**File Stem:** 0000000000-23-001378
**Filing Date:** 2023-2
**Character Count:** 6992
**Document Hash:** a67cc4ab970330e87889e5bfe27af15d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-001378.hdr.sgml**: 20230315

**ACCESSION NUMBER**: 0000000000-23-001378

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230209

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NAVA HEALTH MD, LLC
- **CENTRAL INDEX KEY:** 0001932231
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
- **IRS NUMBER:** 320416441
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 9755 PATUXENT WOODS DRIVE
- **STREET 2:** SUITE 100
- **CITY:** COLUMBIA
- **STATE:** MD
- **ZIP:** 21046
- **BUSINESS PHONE:** 4109102770

**MAIL ADDRESS:**
- **STREET 1:** 9755 PATUXENT WOODS DRIVE
- **STREET 2:** SUITE 100
- **CITY:** COLUMBIA
- **STATE:** MD
- **ZIP:** 21046

## Text-Extract

```

United States securities and exchange commission logo

                             February 9, 2023

       Bernaldo Dancel
       Chief Executive Officer
       NAVA HEALTH MD, LLC
       9755 Patuxent Woods Drive, Suite 100
       Columbia, Maryland 21046

                                                        Re: NAVA HEALTH MD, LLC
                                                            Amendment No. 3 to
Registration Statement on Form S-1
                                                            Filed February 7,
2023
                                                            File No. 333-268022

       Dear Bernaldo Dancel:

              We have reviewed your amended registration statement and have the
following
       comment. In our comment we may ask you to provide us with information so
we may better
       understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comment applies to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to this comment, we may have additional comments.

       Amendment No. 3 to Registration Statement on Form S-1, Filed February 7,
2023

       Exhibits

   1.                                                   We note the opinion
filed as Exhibit 5.1 says "the Secondary Shares will be validly issued
                                                        fully paid and
non-assessable when (i) the Registration Statement, as finally amended,
                                                        shall have been
declared effective under the Securities Act and (ii) the Company   s Board
                                                        or a duly authorized
committee thereof shall have duly adopted final resolutions regarding
                                                        the registration of the
Secondary Shares." Since the shares of common stock in
                                                        the secondary offering
will have already been issued, please have counsel provide
                                                        an opinion that the
shares of common stock in the secondary offering are validly issued,
                                                        fully paid, and
nonassessable and remove conditions (i) and (ii). Finally, please revise to
                                                        state the number of
secondary shares covered by the opinion. Refer to Staff Legal Bulletin
                                                        No. 19 for guidance.
 Bernaldo Dancel
NAVA HEALTH MD, LLC
February 9, 2023
Page 2

       You may contact Tracie Mariner at 202-551-3744 or Al Pavot at
202-551-3738 if you
have questions regarding comments on the financial statements and related
matters. Please
contact Margaret Schwartz at 202-551-7153 or Laura Crotty at 202-551-7614 with
any other
questions.

                                                         Sincerely,

FirstName LastNameBernaldo Dancel                        Division of
Corporation Finance
                                                         Office of Industrial
Applications and
Comapany NameNAVA HEALTH MD, LLC
                                                         Services
February 9, 2023 Page 2
cc:       Rachel M. Jones, Esq.
FirstName LastName

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

CORPORATION FINANCE

# UNITED STATES  
SECURITIES AND EXCHANGE COMMISSION  
WASHINGTON, D.C. 20549

February 9, 2023

Bernaldo Dancel  
Chief Executive Officer  
NAVA HEALTH MD, LLC  
9755 Patuxent Woods Drive, Suite 100  
Columbia, Maryland 21046

# **Re: NAVA HEALTH MD, LLC**  
**Amendment No. 3 to Registration Statement on Form S-1**  
**Filed February 7, 2023**  
**File No. 333-268022**

Dear Bernaldo Dancel:

We have reviewed your amended registration statement and have the following comment. In our comment we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your registration statement and the information you provide in response to this comment, we may have additional comments.

Amendment No. 3 to Registration Statement on Form S-1, Filed February 7, 2023

# Exhibits

1. We note the opinion filed as Exhibit 5.1 says 'the Secondary Shares will be validly issued fully paid and non-assessable when (i) the Registration Statement, as finally amended, shall have been declared effective under the Securities Act and (ii) the Company’s Board or a duly authorized committee thereof shall have duly adopted final resolutions regarding the registration of the Secondary Shares.' Since the shares of common stock in the secondary offering will have already been issued, please have counsel provide an opinion that the shares of common stock in the secondary offering are validly issued, fully paid, and nonassessable and remove conditions (i) and (ii). Finally, please revise to state the number of secondary shares covered by the opinion. Refer to Staff Legal Bulletin No. 19 for guidance.

Bernaldo Dancel
NAVA HEALTH MD, LLC
February 9, 2023
Page 2

You may contact Tracie Mariner at 202-551-3744 or Al Pavot at 202-551-3738 if you have questions regarding comments on the financial statements and related matters. Please contact Margaret Schwartz at 202-551-7153 or Laura Crotty at 202-551-7614 with any other questions.

Sincerely,

Division of Corporation Finance
Office of Industrial Applications and
Services

cc: Rachel M. Jones, Esq.